Globus Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	2,939	2,519	1,568	1,023	958.1
Revenue Growth (YoY)	16.65%	60.62%	53.34%	6.76%	21.43%
Cost of Revenue	938.35	819.88	476.52	262.83	239.22
Gross Profit	2,001	1,699	1,092	760.01	718.88
Selling, General & Admin	1,135	977.48	643.41	432.12	408.15
Research & Development	146.94	161.6	124.01	73.02	97.35
Amortization of Goodwill & Intangibles	118.19	119.37	51.03	17.74	18.53
Operating Expenses	1,400	1,258	818.45	522.87	524.02
Operating Income	600.27	441.03	273.51	237.15	194.86
Interest Expense	-	-4.19	-	-	-
Interest & Investment Income	7.14	-	20.13	14.23	9.3
Currency Exchange Gain (Loss)	-3.01	-43.29	14.26	-1.02	-1.42
Other Non Operating Income (Expenses)	3.41	2.21	-2.14	7.24	3.36
EBT Excluding Unusual Items	607.82	395.76	305.76	257.6	206.09
Merger & Restructuring Charges	-77.35	-274.72	-139.93	-6.85	-16.98
Gain (Loss) on Sale of Investments	-	-	-	-5.39	-2.78
Legal Settlements	-43.1	-0.31	-0.43	-2.34	-5.92
Other Unusual Items	117.7	-	-	-	-
Pretax Income	605.07	120.72	165.39	243.02	180.41
Income Tax Expense	67.2	17.74	42.52	52.85	31.22
Net Income	537.87	102.98	122.87	190.17	149.19
Net Income to Common	537.87	102.98	122.87	190.17	149.19
Net Income Growth	422.28%	-16.19%	-35.39%	27.47%	45.86%
Shares Outstanding (Basic)	135	136	113	100	101
Shares Outstanding (Diluted)	137	138	115	103	104
Shares Change (YoY)	-0.58%	20.27%	11.68%	-0.95%	2.63%
EPS (Basic)	3.98	0.76	1.09	1.89	1.48
EPS (Diluted)	3.92	0.75	1.07	1.85	1.44
EPS Growth	422.67%	-29.91%	-42.16%	28.47%	42.57%
Free Cash Flow	588.77	405.21	165.23	104.42	219.38
Free Cash Flow Per Share	4.30	2.94	1.44	1.02	2.12
Gross Margin	68.07%	67.46%	69.62%	74.30%	75.03%
Operating Margin	20.42%	17.51%	17.44%	23.18%	20.34%
Profit Margin	18.30%	4.09%	7.83%	18.59%	15.57%
Free Cash Flow Margin	20.03%	16.08%	10.53%	10.21%	22.90%
EBITDA	877.11	694.42	419.03	305.4	264.73
EBITDA Margin	29.84%	27.56%	26.72%	29.86%	27.63%
D&A For EBITDA	276.84	253.39	145.53	68.25	69.87
EBIT	600.27	441.03	273.51	237.15	194.86
EBIT Margin	20.42%	17.51%	17.44%	23.18%	20.34%
Effective Tax Rate	11.11%	14.69%	25.71%	21.75%	17.30%

Updated Feb 24, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q